Leadership Overview
Promega has 8 executives leading key functions including strategy, finance, information technology, revenue generation, medical affairs, and general management.
Driven by innovation, Promega is dedicated to advancing scientific discovery and providing essential tools for biotechnology and molecular biology research, impacting fields from genomics to drug discovery.
Driven by innovation, Promega is dedicated to advancing scientific discovery and providing essential tools for biotechnology and molecular biology research, impacting fields from genomics to drug discovery.
Leadership Roles at Promega
Deanna Schuppel - Senior Executive Administrator, Chief Executive Officer
Deanna Schuppel, the Senior Executive Administrator, Chief Executive Officer at Promega, directs critical administrative functions supporting the company's strategic direction. Schuppel ensures operational efficiency across executive operations, facilitating seamless communication and workflow for the leadership team. This role involves managing executive schedules, coordinating high-level meetings, and preparing essential documentation to support decision-making processes. By maintaining robust administrative infrastructure, Deanna Schuppel enables the Chief Executive Officer to focus on overarching company strategy and market positioning. The effective execution of these administrative duties directly contributes to Promega's ability to deliver innovative products in genomics, protein analysis, and cellular research.
Les Louia - President & Chief Executive Officer
Les Louia, the President & Chief Executive Officer at Promega, architects the company's strategic vision and operational execution. Louia drives the overall business direction, guiding Promega's expansion in biotechnology and molecular biology markets. This leadership encompasses overseeing product development, market penetration strategies, and fostering innovation across genomics, protein analysis, and cellular research fields. By championing scientific advancement, Les Louia ensures Promega remains at the forefront of providing essential tools for drug discovery and genetic identity solutions. The executive's focus on long-term growth and market leadership directly impacts the company's global presence and its commitment to supporting scientific breakthroughs.
William Linton - Chairman, Chief Executive Officer & President
William Linton, the Chairman, Chief Executive Officer & President at Promega, establishes the foundational principles and long-term trajectory for the organization. Linton guides the company's mission to empower scientific discovery through advanced biotechnology tools. This comprehensive leadership role involves setting corporate governance standards, driving strategic partnerships, and ensuring Promega's sustained impact in genomics, protein analysis, and cellular biology. By cultivating a culture of innovation and scientific integrity, William Linton directs the company's efforts in developing cutting-edge solutions for drug discovery and genetic identification. The executive's vision shapes Promega's commitment to advancing life sciences globally.
Chris Yarbro - Chief Financial Officer
Chris Yarbro, the Chief Financial Officer at Promega, directs the company's financial strategy and fiscal operations. Yarbro oversees all aspects of financial planning, accounting, and reporting, ensuring robust fiscal health for Promega's diverse product portfolio. This critical role involves managing capital allocation, optimizing financial performance, and mitigating financial risks across global operations. By providing strategic financial insights, Chris Yarbro supports the company's investments in research and development for genomics, protein analysis, and cellular biology. The executive's leadership ensures Promega maintains financial stability while pursuing innovation in drug discovery and genetic identity solutions.
Kristen Yetter - General Manager and President
Kristen Yetter, the General Manager and President at Promega, directs operational management and business development initiatives. Yetter oversees the execution of strategic plans, ensuring efficient operations across Promega's diverse business units. This leadership role involves managing key functional areas to support the company's mission in biotechnology and molecular biology. By focusing on operational excellence, Kristen Yetter enhances Promega's capacity to deliver innovative solutions in genomics, protein analysis, and cellular biology. The executive's management ensures seamless integration of research, development, and market deployment for Promega's essential scientific tools.
Sandra Gardner - Chief Information Officer
Sandra Gardner, the Chief Information Officer at Promega, architects the company's technology infrastructure and digital strategy. Gardner leads the development and implementation of IT solutions that support Promega's global operations and scientific endeavors. This responsibility includes overseeing data management, cybersecurity, and the integration of digital tools across all business functions, from genomics research to product distribution. By ensuring robust and scalable technological systems, Sandra Gardner enhances operational efficiency and supports the company's commitment to innovation in protein analysis and cellular biology. The executive's strategic IT vision empowers Promega's advancements in drug discovery and genetic identity.
Kara Machleidt - Global Chief Revenue Officer, Strategic Business Lead
Kara Machleidt, the Global Chief Revenue Officer, Strategic Business Lead at Promega, drives revenue growth and strategic market expansion. Machleidt oversees global sales operations and develops key business strategies to enhance Promega's market position in biotechnology and molecular biology. This leadership involves identifying new market opportunities, cultivating strategic partnerships, and optimizing revenue streams across the company's product lines, including genomics and protein analysis. By focusing on customer needs and market dynamics, Kara Machleidt ensures Promega's continued success in providing essential tools for cellular analysis and drug discovery. The executive's strategic acumen directly contributes to the company's financial performance and global reach.
Ash Anderson - Chief Medical Officer
Ash Anderson, the Chief Medical Officer at Promega, provides critical medical and scientific expertise to guide product development and research initiatives. Anderson oversees the clinical relevance and application of Promega's technologies, particularly in areas such as cellular analysis and drug discovery. This role involves ensuring that the company's offerings align with current medical research standards and address unmet needs in healthcare and diagnostics. By leveraging deep medical knowledge, Ash Anderson supports the strategic direction of Promega's portfolio, enhancing its impact in genomics and protein analysis. The executive's guidance strengthens Promega's commitment to advancing scientific understanding and improving patient outcomes.
Explore Leadership Teams in Manufacturing
Vertex Pharmaceuticals Incorporated is a biotechnology company that develops and commercializes medicines for serious diseases with significant unmet medical needs. Its portfolio includes therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. The company also advances research programs in kidney disease, type 1 diabetes, myotonic dystrophy, and other genetic disorders, serving patients through healthcare providers, specialty pharmacies, hospitals, and distributors worldwide.
Company Leadership
JL
DD
OG
Bharat Serums And Vaccines Limited (BSV) is one of India's fastest-growing biopharmaceutical companies, dedicated to developing a wide range of biological, biotech, and pharmaceutical products for over 50 years. The company focuses on critical therapeutic areas such as women's health, critical care, and assisted reproductive technology, aiming to improve health and save lives through innovative treatments. BSV is committed to enhancing the quality of life for patients globally, with a strong emphasis on research and development, supported by a team of over 60 scientists. As a part of the Mankind Group, BSV strives to widen accessibility to its products and deliver positive health outcomes.
Company Leadership RA
AS
Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare industries. The company is recognized as a world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that forms, fills, and seals plastic containers in a continuous automated operation, ensuring high levels of sterility and product integrity. Unither's expertise encompasses the development and manufacturing of various liquid dosage forms including oral solutions, suspensions, nasal sprays, eye drops, and other sterile and non-sterile pharmaceutical products delivered in innovative single-dose formats. The company serves a diverse client base of pharmaceutical companies, biotechnology firms, and consumer health brands, providing comprehensive services from formulation development and clinical trial manufacturing to commercial-scale production and packaging. With manufacturing facilities strategically located across multiple continents including Europe and North America, Unither maintains strict quality standards and regulatory compliance with international pharmaceutical guidelines including FDA and EMA requirements. The company emphasizes innovation in drug delivery systems, patient convenience, and sustainability while helping clients bring their pharmaceutical products to market efficiently through its specialized manufacturing capabilities and technical expertise in unit-dose liquid formulations.
Company Leadership
ML
JK
GG
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership
LB
CM
BM
Frequently Asked Questions Regarding Promega Top Executives and Leadership Team
Unlock more people and company data
